American Century Companies
RPTX

American Century Companies’s Repare Therapeutics RPTX Stock Holding History

American Century Companies’s Portfolio RPTX Stock Details RPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-32,802
Closed -$113K – 2946
2024
Q3 		$113K Buy
32,802
+142
+0.4% +$467 ﹤0.01% 2824
2024
Q2 		$108K Buy
32,660
+222
+0.7% +$792 ﹤0.01% 2806
2024
Q1 		$153K Buy
32,438
+6,107
+23% +$39.1K ﹤0.01% 2807
2023
Q4 		$192K Buy
26,331
+8,427
+47% +$47.1K ﹤0.01% 2708
2023
Q3 		$216K Buy
17,904
+5,174
+41% +$53.4K ﹤0.01% 2569
2023
Q2 		$135K Buy
+12,730
New +$131K ﹤0.01% 2619

Other funds holding RPTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

American Century Companies's RPTX Position: Q4 2024 in Review

American Century Companies sold out of Repare Therapeutics (RPTX) in Q4 2024, closing a stake of 32,802 shares — an estimated $113K sold.

American Century Companies first reported a position in RPTX in Q2 2023 and held it in 6 quarters. The position peaked at $216K in Q3 2023. 54 funds tracked by Wall St. Rank hold RPTX as of Q4 2024.

  • American Century Companies reported no remaining Repare Therapeutics position as of Q4 2024 after selling out during the quarter.
  • American Century Companies sold 32,802 Repare Therapeutics shares in Q4 2024, an estimated $113K.
  • American Century Companies first reported a position in Repare Therapeutics in Q2 2023 and held it in 6 quarters.
  • American Century Companies's Repare Therapeutics position peaked at $216K in Q3 2023.
  • 54 funds tracked by Wall St. Rank held Repare Therapeutics as of Q4 2024.

Based on American Century Companies's 13F filing for Q4 2024, filed 11 Feb 2025.